50242-0103
POLIVY
polatuzumab vedotin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
POLATUZUMAB VEDOTIN
30.0
mg/1.88mL
50242-0103-01
1 VIAL in 1 CARTON (50242-103-01) > 6 mL in 1 VIAL
Sept. 18, 2020
Immunotherapy
Drug Antibody Conjugate
CD79b
 
In Use